The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis-Reference-Cited by-同舟云学术

The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis

Published:2012-03-27 Issue:6 Volume:19 Page:563-571
ISSN:1933-7191
Container-title:Reproductive Sciences
language:en
Short-container-title:Reprod Sci

Author:

Chwalisz Kristof¹,Surrey Eric²,Stanczyk Frank Z.³

Affiliation:

1. Abbott Laboratories, Abbott Park, IL, USA

2. Colorado Center for Reproductive Medicine, Lone Tree, CO, USA

3. Departments of Obstetrics and Gynecology, and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1933719112438061

Reference80 articles.

1. Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process

2. Gonadotropin-Releasing Hormone Agonists for Endometriosis

3. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?

4. Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia

5. Bevacizumab: Antiangiogenic cancer therapy

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic approach to the management of menses prophylaxis and suppression in pre-menopausal hematologic cancer patients;Journal of Oncology Pharmacy Practice;2024-07-23

2. Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023;Facts, Views and Vision in ObGyn;2024-04

3. Alternatives to Hysterectomy for Dysfunctional Uterine Bleeding;Hysterectomy Matters;2023-12-13

4. Update on the management of endometriosis-associated pain in France;Journal of Gynecology Obstetrics and Human Reproduction;2023-11

5. Clinical development of the GnRH agonist leuprolide acetate depot;F&S Reports;2022-11